Year |
Citation |
Score |
2021 |
Dai J, Patzke C, Liakath-Ali K, Seigneur E, Südhof TC. GluD1 is a signal transduction device disguised as an ionotropic receptor. Nature. 595: 261-265. PMID 34135511 DOI: 10.1038/s41586-021-03661-6 |
0.407 |
|
2021 |
Patzke C, Dai J, Brockmann MM, Sun Z, Fenske P, Rosenmund C, Südhof TC. Cannabinoid receptor activation acutely increases synaptic vesicle numbers by activating synapsins in human synapses. Molecular Psychiatry. PMID 33931733 DOI: 10.1038/s41380-021-01095-0 |
0.529 |
|
2021 |
Mencacci NE, Brockmann MM, Dai J, Pajusalu S, Atasu B, Campos J, Pino G, Gonzalez-Latapi P, Patzke C, Schwake M, Tucci A, Pittman A, Simon-Sanchez J, Carvill GL, Balint B, et al. Bi-allelic variants in TSPOAP1, encoding the active zone protein RIMBP1, cause autosomal recessive dystonia. The Journal of Clinical Investigation. PMID 33539324 DOI: 10.1172/JCI140625 |
0.493 |
|
2019 |
Patzke C, Brockmann MM, Dai J, Gan KJ, Grauel MK, Fenske P, Liu Y, Acuna C, Rosenmund C, Südhof TC. Neuromodulator Signaling Bidirectionally Controls Vesicle Numbers in Human Synapses. Cell. 179: 498-513.e22. PMID 31585084 DOI: 10.1016/J.Cell.2019.09.011 |
0.56 |
|
2018 |
Zhang Z, Marro SG, Zhang Y, Arendt KL, Patzke C, Zhou B, Fair T, Yang N, Südhof TC, Wernig M, Chen L. The fragile X mutation impairs homeostatic plasticity in human neurons by blocking synaptic retinoic acid signaling. Science Translational Medicine. 10. PMID 30068571 DOI: 10.1126/Scitranslmed.Aar4338 |
0.678 |
|
2016 |
Patzke C, Südhof TC. The conditional KO approach: Cre/Lox technology in human neurons. Rare Diseases (Austin, Tex.). 4: e1131884. PMID 27141410 DOI: 10.1080/21675511.2015.1131884 |
0.657 |
|
2016 |
Patzke C, Acuna C, Giam LR, Wernig M, Südhof TC. Conditional deletion of L1CAM in human neurons impairs both axonal and dendritic arborization and action potential generation. The Journal of Experimental Medicine. 213: 499-515. PMID 27001749 DOI: 10.1084/Jem.20150951 |
0.678 |
|
2016 |
Yi F, Danko T, Botelho SC, Patzke C, Pak C, Wernig M, Südhof TC. Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons. Science (New York, N.Y.). 352: aaf2669. PMID 26966193 DOI: 10.1126/Science.Aaf2669 |
0.676 |
|
2015 |
Patzke C, Han Y, Covy J, Yi F, Maxeiner S, Wernig M, Südhof TC. Analysis of conditional heterozygous STXBP1 mutations in human neurons. The Journal of Clinical Investigation. 125: 3560-71. PMID 26280581 DOI: 10.1172/Jci78612 |
0.591 |
|
2013 |
Zhang Y, Pak C, Han Y, Ahlenius H, Zhang Z, Chanda S, Marro S, Patzke C, Acuna C, Covy J, Xu W, Yang N, Danko T, Chen L, Wernig M, et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron. 78: 785-98. PMID 23764284 DOI: 10.1016/J.Neuron.2013.05.029 |
0.632 |
|
2010 |
Patzke C, Max KE, Behlke J, Schreiber J, Schmidt H, Dorner AA, Kröger S, Henning M, Otto A, Heinemann U, Rathjen FG. The coxsackievirus-adenovirus receptor reveals complex homophilic and heterophilic interactions on neural cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 2897-910. PMID 20181587 DOI: 10.1523/Jneurosci.5725-09.2010 |
0.574 |
|
Low-probability matches (unlikely to be authored by this person) |
2018 |
Szoch S, Boord C, Duffy A, Patzke C. Addressing Administration Challenges Associated With Blinatumomab Infusions: A Multidisciplinary Approach. Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society. 41: 241-246. PMID 29958260 DOI: 10.1097/NAN.0000000000000283 |
0.115 |
|
2019 |
Adige S, Lapidus RG, Carter-Cooper BA, Duffy A, Patzke C, Law JY, Baer MR, Ambulos NP, Zou Y, Bentzen SM, Emadi A. Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation. Cancer Chemotherapy and Pharmacology. PMID 30968179 DOI: 10.1007/S00280-019-03825-2 |
0.085 |
|
2020 |
Patzke CL, Emadi A. High dose cytarabine, mitoxantrone, pegasapargase (HAM-pegA) in combination with dasatinib for the first-line treatment of Philadelphia chromosome positive mixed phenotype acute leukemia. American Journal of Leukemia Research. 4. PMID 33283208 |
0.077 |
|
2020 |
Patzke CL, Duffy AP, Duong VH, El Chaer F, Trovato JA, Baer MR, Bentzen SM, Emadi A. Comparison of High-Dose Cytarabine, Mitoxantrone, and Pegaspargase (HAM-pegA) to High-Dose Cytarabine, Mitoxantrone, Cladribine, and Filgrastim (CLAG-M) as First-Line Salvage Cytotoxic Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia. Journal of Clinical Medicine. 9. PMID 32079074 DOI: 10.3390/Jcm9020536 |
0.038 |
|
2019 |
Bade NA, Lu C, Patzke CL, Baer MR, Duong VH, Law JY, Lee ST, Sausville EA, Zimrin AB, Duffy AP, Lawson J, Emadi A. Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and management. Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners. 1078155219838316. PMID 30917738 DOI: 10.1177/1078155219838316 |
0.034 |
|
2019 |
Patzke CL, Armahizer MJ, Badjatia N, Motta M. A Retrospective Analysis of Prolonged Empiric Antibiotic Therapy for Pneumonia Among Adult Neurocritical Care Patients. The Neurohospitalist. 9: 15-21. PMID 30671159 DOI: 10.1177/1941874418792138 |
0.031 |
|
2018 |
Prescott GM, Patzke CL, Brody PM, Prescott WA. Comparison of prescribing patterns between United States and Dominican Republic prescribers on short-term medical mission trips. International Health. 10: 27-32. PMID 29309591 DOI: 10.1093/inthealth/ihx045 |
0.01 |
|
Hide low-probability matches. |